1. Volume 5, Issue 5, Pages 639-642 (May 2008)
Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: A report from the Canadian Heart Rhythm Society Device Advisory Committee 
Andrew D. Krahn, MD, Jean Champagne, MD, Jeffrey S. Healey, MD, Doug Cameron, MD, Christopher S. Simpson, MD, Bernard Thibault, MD, Iqwal Mangat, MD, Stanley Tung, MD, Laurence Sterns, MD, David H. Birnie, MD, Derek V. Exner, MD, Ratika Parkash, MD, Soori Sivakumaran, MD, Ted Davies, MD, Benoit Coutu, MD, Eugene Crystal, MD, Kevin Wolfe, MD, Atul Verma, MD, Elizabeth A. Stephenson, MD, Shubhayan Sanatani, MD, Robert Gow, MD, Sean Connors, MD, Felix Ayala Paredes, MD, PhD, Vidal Essebag, MD, PhD 
Heart Rhythm 
Volume 5, Issue 5, Pages (May 2008)
DOI: /j.hrthm
Copyright © 2008 Heart Rhythm Society Terms and Conditions

2. Figure 1
Volume of leads implanted in each of the 23 centers. Note that three pediatric centers have been combined for purpose of analysis.
Heart Rhythm 2008 5, DOI: ( /j.hrthm )
Copyright © 2008 Heart Rhythm Society Terms and Conditions

3. Figure 2
Number of inappropriate shocks experienced by patients presenting with lead fracture. Five patients experienced a single shock. Patient 44 experienced 122 shocks. One patient experienced inappropriate shocks while traveling in a foreign country, and device interrogation was not available.
Heart Rhythm 2008 5, DOI: ( /j.hrthm )
Copyright © 2008 Heart Rhythm Society Terms and Conditions

4. Figure 3
Individual center failure rates listed by centers from smallest to largest with respect to implant volumes, in the same order as Figure 1.Note the lack of relationship between implant volumes and failure rate, and that higher volume centers all experienced at least one failure. Center 2 experienced two failures (6.3%) among 32 pediatric patients.
Heart Rhythm 2008 5, DOI: ( /j.hrthm )
Copyright © 2008 Heart Rhythm Society Terms and Conditions